H56:IC31

· International AIDS Vaccine Initiative

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for H56:IC31, covering 2018-04-10 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence [Phase 2]